The Key Structural Difference: Glycine vs Alanine Both peptides are three amino acids long
In one study, 74.2% of patients on a GLP-1 reported GI symptoms
According to clinical trials, gastrointestinal symptoms typically peak during the first 48 weeks of therapy, with substantial improvement for many patients by 1216 weeks, though individual experiences vary based on the specific medication and titration schedule
As a result, drugs targeting GLP-1 may be better treatments for obesity-related type 2 diabetes than other antidiabetic agents, whch often tend to promote weight gain
The goal is to choose the smallest set of levers that measurably reduces insulin dose requirements, improves predictability, and lowers glucose exposure over time, worth exploring with your diabetes care team